Cephalon Can't Ditch FCA Claims In Off-Label Marketing Suit
A Pennsylvania federal judge on Tuesday refused Cephalon Inc.'s bid to dismiss claims in a False Claims Act dispute alleging the pharmaceutical company improperly promoted drugs for off-label uses, finding the...To view the full article, register now.
Already a subscriber? Click here to view full article